Key Facts

—The launch. Suzano and Kimberly-Clark closed their tissue deal on July 1 and began operating a new firm called Arbex.

—The payment. Suzano settled the deal for about US$1.3bn (R$6.7bn), adjusted from the US$1.734bn first agreed.

—The stakes. Suzano holds 51% and Kimberly-Clark 49% of the new company, valued in June 2025 at US$3.4bn.

—The scale. Arbex runs 22 plants in 14 countries, employs about 9,000 people and expects roughly US$3.3bn in annual sales.